National Institute on Drug Abuse; Notice of Closed Meeting, 57682 [2021-22643]

Download as PDF 57682 Federal Register / Vol. 86, No. 198 / Monday, October 18, 2021 / Notices Contact Person: Chee Lim, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4128, Bethesda, MD 20892, (301) 435–1850, limc4@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 12, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. Dated: October 13, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–22643 Filed 10–15–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Meeting [FR Doc. 2021–22555 Filed 10–15–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting jspears on DSK121TN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA and NIAAA Institutional Research Training Grant (T32/T35) Review Panel. Date: November 10–12, 2021. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827–5702, sindhu.kizhakkemadathil@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) VerDate Sep<11>2014 18:28 Oct 15, 2021 Jkt 256001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIA. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL INSTITUTE ON AGING, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIA. Date: October 19–21, 2021. Closed: October 19, 2021, 9:00 a.m. to 9:45 a.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 19, 2021, 9:45 a.m. to 12:45 p.m. Agenda: Committee discussion, individual presentations, laboratory overview. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 19, 2021, 12:45 p.m. to 1:30 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 19, 2021, 1:30 p.m. to 3:30 p.m. Agenda: Committee discussion, individual presentations, laboratory overview. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 19, 2021, 3:30 p.m. to 5:30 p.m. Agenda: To review and evaluate committee discussion, individual presentations, laboratory overview. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 20, 2021, 9:00 a.m. to 9:15 a.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 20, 2021, 9:15 a.m. to 10:45 a.m. Agenda: Committee discussion, individual presentations, laboratory overview. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 20, 2021, 10:45 a.m. to 3:00 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 21, 2021, 9:00 a.m. to 9:15 a.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 21, 2021, 9:15 a.m. to 10:45 a.m. Agenda: Committee discussion, individual presentations, laboratory overview. Place: National Institute on Aging, Biomedical Research Center, 3rd Floor, Conference Room 03C227, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 21, 2021, 10:45 a.m. to 12:30 p.m. Agenda: To review and evaluate committee discussion, individual presentations, laboratory overview. E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 86, Number 198 (Monday, October 18, 2021)]
[Notices]
[Page 57682]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-22643]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA and NIAAA Institutional Research Training Grant 
(T32/T35) Review Panel.
    Date: November 10-12, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific 
Review Officer, Scientific Review Branch, National Institute on Drug 
Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 
20892, (301) 827-5702, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: October 13, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-22643 Filed 10-15-21; 8:45 am]
BILLING CODE 4140-01-P